Loading…
LncRNA625 inhibits STAT1-mediated transactivation potential in esophageal cancer cells
•LncRNA625 inhibits STAT1-mediated transcriptional activation.•LncRNA625 interacts with STAT1.•LncRNA625 promotes STAT1 interaction with TC45. Although Signal transducer and activator of transcription 1 (STAT1)-mediated transactivation potential is inhibited in cancer cells, the mechanism is poorly...
Saved in:
Published in: | The international journal of biochemistry & cell biology 2019-12, Vol.117, p.105626-105626, Article 105626 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | •LncRNA625 inhibits STAT1-mediated transcriptional activation.•LncRNA625 interacts with STAT1.•LncRNA625 promotes STAT1 interaction with TC45.
Although Signal transducer and activator of transcription 1 (STAT1)-mediated transactivation potential is inhibited in cancer cells, the mechanism is poorly understood. In the present study, we implicated long non-coding RNA lncRNA625 in the inhibition of STAT1 activity. LncRNA625 knockdown up-regulated STAT1-mediated transcription and resulted in an increase of STAT1-mediated expression of IFITM2. Conversely, lncRNA625 upregulation inhibited STAT1 reporter activity. Mechanistically, lncRNA625 inhibited STAT1 binding to the promoter of IFITM2 in both untreated cells and following interferon-gamma (IFN-γ) stimulation. LncRNA625 interacted with the DNA-binding (DB) domain of STAT1 and promoted STAT1 interaction with T-cell protein tyrosine phosphatase TC45 to dephosphorylate pSTAT1. Taken together, the results show that lncRNA625 inhibits STAT1-mediated transactivation potential by causing formation of STAT1-TC45 complexes, resulting in STAT1 dephosphorylation. |
---|---|
ISSN: | 1357-2725 1878-5875 |
DOI: | 10.1016/j.biocel.2019.105626 |